Insights of lyotropic liquid crystals in topical drug delivery for targeting various skin disorders

被引:70
作者
Rapalli, Vamshi Krishna [1 ]
Waghule, Tejashree [1 ]
Hans, Neha [1 ]
Mahmood, Arisha [1 ]
Gorantla, Srividya [1 ]
Dubey, Sunil Kumar [1 ]
Singhvi, Gautam [1 ]
机构
[1] Birla Inst Technol & Sci, Dept Pharm, Ind Res Lab, Pilani 333031, Rajasthan, India
关键词
Cubosomes; Hexosomes; Liquid crystalline nanoparticles; Lyotropic liquid crystal; Skin disorders; Topical drug delivery; SURFACTANT-BASED SYSTEMS; IN-VITRO; TRANSDERMAL DELIVERY; LIPID NANOPARTICLES; VIVO; FORMULATION; MONOOLEIN; DESIGN; ACID; NANOCARRIERS;
D O I
10.1016/j.molliq.2020.113771
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Lyotropic liquid crystal (LLCs) based drug delivery systems remain in the transitional state of solid and liquid. They are divided into three types: lamellar, cubic, and hexagonal based on the organization. LLCs form compartments on dispersion in the aqueous phase, which can entrap both hydrophilic and lipophilic moieties. The arrangement of lipids, size, and shape can be modified based on water content, lipid concentration, and the additives added to the mixture. The variation in the formulation aspects can be useful to modify the drug release in a controlled manner. The lipids used in LLCs formulation exhibit structural similarities with the skin membrane. These advantages of LLCs formulation favor the efficient delivery of drugs in various skin disorders. The lipophilic nature provides increased permeation, and the bio-adhesive property while the nanosize favors the occlusive nature. The physicochemical properties of LLCs based formulations make it apposite for topical delivery in targeting superficial layers in skin disorders. The review gives insights into LLCs based formulation for the delivery of therapeutics in skin disorders. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:12
相关论文
共 74 条
[1]   "Liquid Crystalline Nanoparticles": Rationally Designed Vehicle To Improve Stability and Therapeutic Efficacy of Insulin Following Oral Administration [J].
Agrawal, Ashish Kumar ;
Kumar, Kuldeep ;
Swarnakar, Nitin Kumar ;
Kushwah, Varun ;
Jain, Sanyog .
MOLECULAR PHARMACEUTICS, 2017, 14 (06) :1874-1882
[2]  
Akhtar N., 2017, B FAC PHARM CAIRO, V55, P1, DOI DOI 10.1016/J.BFOPCU.2016.12.003
[3]   Nanotechnology in Dermatology [J].
Antonio, Joao Roberto ;
Antnio, Carlos Roberto ;
Soares Cardeal, Izabela Lidia ;
Avelino Ballavenuto, Julia Maria ;
Oliveira, Joao Rodrigo .
ANAIS BRASILEIROS DE DERMATOLOGIA, 2014, 89 (01) :126-136
[4]  
Ashok C.K., 2019, Int J All Res Writ, V1, P119
[5]   Effect of silver on burn wound infection control and healing: Review of the literature [J].
Atiyeh, Bishara S. ;
Costagliola, Michel ;
Hayek, Shady N. ;
Dibo, Saad A. .
BURNS, 2007, 33 (02) :139-148
[6]   Formulation and characterization of liquid crystal systems containing azelaic acid for topical delivery [J].
Aytekin, Merve ;
Gursoy, R. Neslihan ;
Ide, Semra ;
Soylu, Elif H. ;
Hekimoglu, Sueda .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (02) :228-239
[7]   Polymer-free cubosomes for simultaneous bioimaging and photodynamic action of photosensitizers in melanoma skin cancer cells [J].
Bazylinska, Urszula ;
Kulbacka, Julita ;
Schmidt, Judith ;
Talmon, Yeshayahu ;
Murgia, Sergio .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2018, 522 :163-173
[8]   Lipid cubic phases in topical drug delivery:: Visualization of skin distribution using two-photon microscopy [J].
Bender, Johanna ;
Simonsson, Carl ;
Smedh, Maria ;
Engstrom, Sven ;
Ericson, Marica B. .
JOURNAL OF CONTROLLED RELEASE, 2008, 129 (03) :163-169
[9]   Papaverine hydrochloride containing nanostructured lyotropic liquid crystal formulation as a potential drug delivery system for the treatment of erectile dysfunction [J].
Berko, Szilvia ;
Zsiko, Stella ;
Deak, Gabor ;
Gacsi, Attila ;
Kovacs, Anita ;
Budai-Szucs, Maria ;
Pajor, Laszlo ;
Bajory, Zoltan ;
Csanyi, Erzsebet .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 :2923-2931
[10]   Cubosomes for topical delivery of the antimicrobial peptide LL-37 [J].
Boge, Lukas ;
Hallstensson, Karin ;
Ringstad, Lovisa ;
Johansson, Jenny ;
Andersson, Therese ;
Davoudi, Mina ;
Larsson, Per Tomas ;
Mahlapuu, Margit ;
Hakansson, Joakim ;
Andersson, Martin .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2019, 134 :60-67